Impact of asialoglycoprotein receptor deficiency on the development of liver injury

World Journal of Gastroenterology

Volumn 15, Issue 10, 2009, Pages 1194-1200

  Lee, Serene M L ^a   Casey, Carol A ^a   McVicker, Benita L ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Alcohol; Anti fas; Asialoglycoprotein receptor; Asialoglycoprotein receptor deficient mice; Carbon tetrachloride; Lipopolysaccharide galactosamine; Receptor mediated endocytosis; Toxicant induced liver injury

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASIALOGLYCOPROTEIN RECEPTOR; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CASPASE; FAS ANTIBODY; GALACTOSAMINE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; APOPTOSIS; ARTICLE; ASIALOGLYCOPROTEIN RECEPTOR DEFICIENCY; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL ACTIVATION; ENDOCYTOSIS; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; KUPFFER CELL; LIGAND BINDING; LIVER INJURY; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RECEPTOR BINDING; ANIMAL; GENETICS; HUMAN; INJURY; INTOXICATION; LIVER; LIVER DISEASE; METABOLISM; MOUSE; MOUSE MUTANT; RAT; REVIEW;

ANIMALS; ASIALOGLYCOPROTEIN RECEPTOR; CARBON TETRACHLORIDE POISONING; HUMANS; LIVER; LIVER DISEASES; MICE; MICE, KNOCKOUT; RATS; RNA, MESSENGER;

EID: 65649123336     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.1194     Document Type: Article

References (79)

1. Ashwell G, Morell AG. The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol Relat Areas Mol Biol 1974; 41: 99-128
2. Ashwell G, Kawasaki T. A protein from mammalian liver that specifically binds galactose-terminated glycoproteins. Methods Enzymol 1978; 50: 287-288
3. Ashwell G, Steer CJ. Hepatic recognition and catabolism of serum glycoproteins. JAMA 1981; 246: 2358-2364
4. Casey CA, Kragskow SL, Sorrell MF, Tuma DJ. Chronic ethanol administration impairs the binding and endocytosis of asialo-orosomucoid in isolated hepatocytes. J Biol Chem 1987; 262: 2704-2710
5. Stockert RJ. The asialoglycoprotein receptor: relationships between structure, function, and expression. Physiol Rev 1995; 75: 591-609
6. Weigel PH. Endocytosis and function of the hepatic asialoglycoprotein receptor. Subcell Biochem 1993; 19: 125-161
7. Debanne MT, Evans WH, Flint N, Regoeczi E. Receptor-rich intracellular membrane vesicles transporting asialotransferrin and insulin in liver. Nature 1982; 298: 398-400
8. Meijer DK, Scholtens HB, Hardonk MJ. The role of the liver in clearance of glycoproteins from the general circulation, with special reference to intestinal alkaline phosphatase. Pharm Weekbl Sci 1982; 4: 57-70
9. Tomana M, Phi l l ips JO, Kulhavy R, Me s t e cky J. Carbohydrate-mediated clearance of secretory IgA from the circulation. Mol Immunol 1985; 22: 887-892
10. Dini L, Autuori F, Lentini A, Oliverio S, Piacentini M. The clearance of apoptotic cells in the liver is mediated by the asialoglycoprotein receptor. FEBS Lett 1992; 296: 174-178
11. McVicker BL, Tuma DJ, Kubik JA, Hindemith AM, Baldwin CR, Casey CA. The effect of ethanol on asialoglycoprotein receptor-mediated phagocytosis of apoptotic cells by rat hepatocytes. Hepatology 2002; 36: 1478-1487
12. Rotundo RF, Rebres RA, Mckeown-Longo PJ, Blumenstock FA, Saba TM. Circulating cellular fibronectin may be a natural ligand for the hepatic asialoglycoprotein receptor: possible pathway for fibronectin deposition and turnover in the rat liver. Hepatology 1998; 28: 475-485
13. Grewal PK, Uchiyama S, Ditto D, Varki N, Le DT, Nizet V, Marth JD. The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat Med 2008; 14: 648-655
14. Sawamura T, Nakada H, Hazama H, Shiozaki Y, Sameshima Y, Tashiro Y. Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma. Asialoglycoprotein receptor in cirrhosis and liver cell carcinoma. Gastroenterology 1984; 87: 1217-1221
15. Virgolini I, Muller C, Klepetko W, Angelberger P, Bergmann H, O'Grady J, Sinzinger H. Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand. Br J Cancer 1990; 61: 937-941
16. Kung HC, Hoyert DL, Xu J, Murphy SL. Deaths: final data for 2005. Natl Vital Stat Rep 2008; 56: 1-120
17. Drickamer K, Mamon JF, Binns G, Leung JO. Primary structure of the rat liver asialoglycoprotein receptor. Structural evidence for multiple polypeptide species. J Biol Chem 1984; 259: 770-778
18. Halberg DF, Wager RE, Farrell DC, Hildreth J 4th, Quesenberry MS, Loeb JA, Holland EC, Drickamer K. Major and minor forms of the rat liver asialoglycoprotein receptor are independent galactose-binding proteins. Primary structure and glycosylation heterogeneity of minor receptor forms. J Biol Chem 1987; 262: 9828-9838
19. Nakada H, Matsuura S, Sawamura T, Tashiro Y. Topology of asialoglycoprotein receptor in rat liver subcellular fractions: a ferritin immunoelectron microscopic study. Cell Struct Funct 1984; 9: 391-406
20. Stockert RJ, Potvin B, Tao L, Stanley P, Wolkoff AW. Human hepatoma cell mutant defective in cell surface protein trafficking. J Biol Chem 1995; 270: 16107-16113
21. Weigel PH, Medh JD, Oka JA. A novel cycle involving fatty acyl-coenzyme A regulates asialoglycoprotein receptor activity in permeable hepatocytes. Mol Biol Cell 1994; 5: 227-235
22. Weigel PH, Oka JA. Regulation of asialoglycoprotein receptor activity by a novel inactivation/reactivation cycle. Receptor reactivation in permeable rat hepatocytes is mediated by fatty acyl coenzyme A. J Biol Chem 1993; 268: 27186-27190
23. Tworek BL, Tuma DJ, Casey CA. Decreased binding of asialoglycoproteins to hepatocytes from ethanol-fed rats. Consequence of both impaired synthesis and inactivation of the asialoglycoprotein receptor. J Biol Chem 1996; 271: 2531-2538
24. Tworek BL, Oka JA, Casey CA, Weigel PH. Ethanol feeding causes inactivation of both state 1 and state 2 rat hepatic asialoglycoprotein receptors. Alcohol Clin Exp Res 1997; 21: 1429-1434
25. McVicker BL, Tuma DJ, Casey CA. Hyperphosphorylation of the asialoglycoprotein receptor in isolated rat hepatocytes following ethanol administration. Biochem Pharmacol 2000; 60: 343-351
26. Hong W, Le AV, Doyle D. Identification and characterization of a murine receptor for galactose-terminated glycoproteins. Hepatology 1988; 8: 553-558
27. Ishibashi S, Hammer RE, Herz J. Asialoglycoprotein receptor deficiency in mice lacking the minor receptor subunit. J Biol Chem 1994; 269: 27803-27806
28. Braun JR, Willnow TE, Ishibashi S, Ashwell G, Herz J. The major subunit of the asialoglycoprotein receptor is expressed on the hepatocellular surface in mice lacking the minor receptor subunit. J Biol Chem 1996; 271: 21160-21166
29. Casey CA, Sorrell MF, Tuma DJ. Effect of ethanol on asialoglycoprotein receptor function. Targeted Diagn Ther 1991; 4: 189-213
30. Mailliard ME, Sorrell MF, Volentine GD, Tuma DJ. Impaired plasma membrane glycoprotein assembly in the liver following acute ethanol administration. Biochem Biophys Res Commun 1984; 123: 951-958
31. Sorrell MF, Tuma DJ. Hypothesis: alcoholic liver injury and the covalent binding of acetaldehyde. Alcohol Clin Exp Res 1985; 9: 306-309
32. Tuma DJ, Sorrell MF. Effects of ethanol on protein trafficking in the liver. Semin Liver Dis 1988; 8: 69-80
33. Tuma DJ, Casey CA, Sorrell MF. Effects of ethanol on hepatic protein trafficking: impairment of receptor-mediated endocytosis. Alcohol Alcohol 1990; 25: 117-125
34. Wu D, Cederbaum AI. Ethanol cytotoxicity to a transfected HepG2 cell line expressing human cytochrome P4502E1. J Biol Chem 1996; 271: 23914-23919
35. Castillo T, Koop DR, Kamimura S, Triadafilopoulos G, Tsukamoto H. Role of cytochrome P-450 2E1 in ethanol-, carbon tetrachloride- and iron-dependent microsomal lipid peroxidation. Hepatology 1992; 16: 992-996
36. Chen Q, Galleano M, Cederbaum AI. Cytotoxicity and apoptosis produced by arachidonic acid in Hep G2 cells overexpressing human cytochrome P4502E1. J Biol Chem 1997; 272: 14532-14541
37. Hoek JB, Pastorino JG. Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol 2002; 27: 63-68
38. McClain CJ, Barve S, Deaciuc I, Kugelmas M, Hill D. Cytokines in alcoholic liver disease. Semin Liver Dis 1999; 19: 205-219
39. McVicker BL, Tuma DJ, Kubik JL, Tuma PL, Casey CA. Ethanol-induced apoptosis in polarized hepatic cells possibly through regulation of the Fas pathway. Alcohol Clin Exp Res 2006; 30: 1906-1915
40. Casey CA, Kragskow SL, Sorrell MF, Tuma DJ. Ethanol-induced impairments in receptor-mediated endocytosis of asialoorosomucoid in isolated rat hepatocytes: time course of impairments and recovery after ethanol withdrawal. Alcohol Clin Exp Res 1989; 13: 258-263
41. Casey CA, Volentine GD, Jankovich CJ, Kragskow SL, Tuma DJ. Effect of chronic ethanol administration on the uptake and degradation of asialoglycoproteins by the perfused rat liver. Biochem Pharmacol 1990; 40: 1117-1123
42. Casey CA, Tuma DJ. Receptors and endocytosis. In: LeBouton AV. Molecular and Cell Biology of the Liver. Ann Arbor: CRC Press, 1993: 117-141
43. Casey CA, McVicker BL, Donohue TM Jr, McFarland MA, Wiegert RL, Nanji AA. Liver asialoglycoprotein receptor levels correlate with severity of alcoholic liver damage in rats. J Appl Physiol 2004; 96: 76-80
44. Dalton SR, Wiegert RL, Baldwin CR, Kassel KM, Casey CA. Impaired receptor-mediated endocytosis by the asialoglycoprotein receptor in ethanol-fed mice: implications for studying the role of this receptor in alcoholic apoptosis. Biochem Pharmacol 2003; 65: 535-543
45. McVicker BL, Tuma DJ, Kharbanda KK, Kubik JL, Casey CA. Effect of chronic ethanol administration on the in vitro production of proinflammatory cytokines by rat Kupffer cells in the presence of apoptotic cells. Alcohol Clin Exp Res 2007; 31: 122-129
46. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S. Lethal effect of the anti-Fas antibody in mice. Nature 1993; 364: 806-809
47. Schutze S, Tchikov V, Schneider-Brachert W. Regulation of TNFR1 and CD95 signalling by receptor compartmentalization. Nat Rev Mol Cell Biol 2008; 9: 655-662
48. Malhi H, Gores GJ. Cellular and molecular mechanisms of liver injury. Gastroenterology 2008; 134: 1641-1654
49. Kakinuma C, Takagaki K, Yatomi T, Nakamura N, Nagata S, Uemura A, Shibutani Y. Acute toxicity of an anti-Fas antibody in mice. Toxicol Pathol 1999; 27: 412-420
50. Nishimura Y, Hirabayashi Y, Matsuzaki Y, Musette P, Ishii A, Nakauchi H, Inoue T, Yonehara S. In vivo analysis of Fas antigen-mediated apoptosis: effects of agonistic anti-mouse Fas mAb on thymus, spleen and liver. Int Immunol 1997; 9: 307-316
51. Baldwin CR, Radio, SJ, Kassel KM, Dalton, SR, McVicker BL, Kubik JL, Wiegert RL, Casey CA. Increased susceptibility to anti-fas antibody-induced liver injury in an asialoglycoprotein receptor deficient mouse. Hepatology 2002; 36: 324A
52. Manibusan MK, Odin M, Eastmond DA. Postulated carbon tetrachloride mode of action: a review. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2007; 25: 185-209
53. Weber LW, Boll M, Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 2003; 33: 105-136
54. Shi J, Aisaki K, Ikawa Y, Wake K. Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride. Am J Pathol 1998; 153: 515-525
55. McVicker BL, Nanji AA, Lee SM, Kharbanda KK, Casey CA. Asialoglycoprotein receptor deficiency increases carbon tetrachloride-induced liver damage in a mouse model. Hepatology 2008; 48: 468A
56. Decker K, Keppler D. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev Physiol Biochem Pharmacol 1974; 77-106
57. Farber JL, Gill G, Konishi Y. Prevention of galactosamine-induced liver cell necrosis by uridine. Am J Pathol 1973; 72: 53-62
58. El-Mofty SK, Scrutton MC, Serroni A, Nicolini C, Farber JL. Early, reversible plasma membrane injury in galactosamine-induced liver cell death. Am J Pathol 1975; 79: 579-596
59. Keppler D, Lesch R, Reutter W, Decker K. Experimental hepatitis induced by D-galactosamine. Exp Mol Pathol 1968; 9: 279-290
60. Galanos C, Freudenberg MA, Reutter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci USA 1979; 76: 5939-5943
61. Endo Y, Shibazaki M, Yamaguchi K, Kai K, Sugawara S, Takada H, Kikuchi H, Kumagai K. Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment. Br J Pharmacol 1999; 128: 5-12
62. Freudenberg MA, Galanos C. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect Immun 1988; 56: 1352-1357
63. Freudenberg MA, Galanos C. Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and grampositive bacteria in D-galactosamine-treated mice. Infect Immun 1991; 59: 2110-2115
64. Tiegs G, Wolter M, Wendel A. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol 1989; 38: 627-631
65. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995; 146: 1220-1234
66. Casey CA, Mulcahy EC, Wiegert RL, Wagner ZC, McVicker BL, Kharbanda KK. Mice lacking functional asialoglycoprotein receptor show increased susceptibility to D-galactosamine/lipopolysaccharide-induced liver injury. Hepatology 2006; 44: 387A
67. Lee SM, Casey CA, McVicker BL, Kharbanda KK. Increased production of interleukin-6 in asialoglycoprotein receptor deficient mice after D-galactosamine/lipopolysaccharide-induced liver injury. Alcohol Clin Exp Res 2008; 32: 37A
68. Hockenbery D. Defining apoptosis. Am J Pathol 1995; 146: 16-19
69. Benedetti A, Brunelli E, Risicato R, Cilluffo T, Jezequel AM, Orlandi F. Subcellular changes and apoptosis induced by ethanol in rat liver. J Hepatol 1988; 6: 137-143
70. Deaciuc IV, Fortunato F, D'Souza NB, Hill DB, Schmidt J, Lee EY, McClain CJ. Modulation of caspase-3 activity and Fas ligand mRNA expression in rat liver cells in vivo by alcohol and lipopolysaccharide. Alcohol Clin Exp Res 1999; 23: 349-356
71. Goldin RD, Hunt NC, Clark J, Wickramasinghe SN. Apoptotic bodies in a murine model of alcoholic liver disease: reversibility of ethanol-induced changes. J Pathol 1993; 171: 73-76
72. Natori S, Rust C, Stadheim LM, Srinivasan A, Burgart LJ, Gores GJ. Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J Hepatol 2001; 34: 248-253
73. Yacoub LK, Fogt F, Griniuviene B, Nanji AA. Apoptosis and bcl-2 protein expression in experimental alcoholic liver disease in the rat. Alcohol Clin Exp Res 1995; 19: 854-859
74. Zhao M, Laissue JA, Zimmermann A. TUNEL-positive hepatocytes in alcoholic liver disease. A retrospective biopsy study using DNA nick end-labelling. Virchows Arch 1997; 431: 337-344
75. Ziol M, Tepper M, Lohez M, Arcangeli G, Ganne N, Christidis C, Trinchet JC, Beaugrand M, Guillet JG, Guettier C. Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis. J Hepatol 2001; 34: 254-260
76. Savill J, Dransfield I, Hogg N, Haslett C. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 1990; 343: 170-173
77. Owens MR, Cimino CD. Synthesis of fibronectin by the isolated perfused rat liver. Blood 1982; 59: 1305-1309
78. Ruoslahti E, Engvall E, Hayman EG. Fibronectin: current concepts of its structure and functions. Coll Relat Res 1981; 1: 95-128
79. Ballardini G, Faccani A, Fallani M, Berti S, Vasi V, Castaldini C, Biagini G, Garbisa S, Bianchi FB. Sequential behaviour of extracellular matrix glycoproteins in an experimental model of hepatic fibrosis. Virchows Arch B Cell Pathol Incl Mol Pathol 1985; 49: 317-324